Copyright: ©Author(s) 2026.
World J Clin Oncol. Aug 24, 2026; 17(8): 123328
Published online Aug 24, 2026. doi: 10.5306/wjco.123328
Published online Aug 24, 2026. doi: 10.5306/wjco.123328
Figure 3 Distribution of VHL mutation status according to histological subtype.
Stacked bar chart showing the distribution of VHL-mutated (VHL+) and VHL wild-type (VHL-) tumors according to renal cell carcinoma histological subtype. VHL mutations were predominantly identified in clear-cell renal cell carcinoma (RCC), whereas relatively few mutations were observed in non-clear-cell RCC. RCC: Renal cell carcinoma.
- Citation: Talwar V, Jain A, Goel V, Agarwal B, Gupta P, Tripathi R, Rawal S, Mehta A. Genomic landscape and clinical actionability of renal cell carcinoma in an Indian cohort: A real-world targeted next-generation sequencing study. World J Clin Oncol 2026; 17(8): 123328
- URL: https://www.wjgnet.com/2218-4333/full/v17/i8/123328.htm
- DOI: https://dx.doi.org/10.5306/wjco.123328